Literature DB >> 35595844

Does the moderator matter? Identification of multiple moderators of the association between peripheral inflammatory markers and depression severity in a large racially diverse community cohort.

Manivel Rengasamy1, Sophia Arruda Da Costa E Silva2, Meredith Spada2, Rebecca B Price2,3.   

Abstract

Depressive symptomology has been linked to low-grade peripheral inflammatory markers (PIMs), specifically C-reactive protein (CRP) and white blood cell count (WBC). However, such associations may be affected by multiple moderators (including race/ethnicity), though few well-powered and racially diverse studies have examined this. We examined 31 moderators of PIM-depression relationships in a large racially diverse cohort (n = 21,570). We also examined if associations between PIM and depression severity were dependent on clinical cutpoints for moderate depressive symptoms and elevated CRP. We found several positive moderators of PIM-depression relationships for both WBC and CRP: ongoing medication use (antidepressant, statin, or any prescription drug), presence of sleep concerns, and poor health status (β's = 0.06-0.21, p's < 0.05). For both WBC and CRP, individuals of non-Hispanic White race/ethnicity were found to have stronger PIM-depression associations overall relative to minoritized groups (B's = 0.14 to 1.01, p's < 0.05). For CRP, stronger PIM-depression relationships existed for individuals with moderate (or greater) depression severity or elevated CRP (B's = 0.27 to 0.49, p's < 0.05). Thus, a wide range of moderators appears to affect PIM-depression associations. These results could help identify participants with strong coupling of PIM-depression severity, to guide future research and personalized treatments for depression and to indicate gaps in the applicability of widely referenced theoretical models among racial/ethnic minoritized groups.
© 2022. The Author(s), under exclusive licence to American College of Neuropsychopharmacology.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35595844      PMCID: PMC9283451          DOI: 10.1038/s41386-022-01341-1

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   8.294


  41 in total

1.  Measurement of proteins with the Behring Nephelometer. A multicentre evaluation.

Authors:  P C Fink; M Römer; R Haeckel; A Fateh-Moghadam; J Delanghe; A M Gressner; R W Dubs
Journal:  J Clin Chem Clin Biochem       Date:  1989-04

Review 2.  Neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress.

Authors:  Nathan L Sparkman; Rodney W Johnson
Journal:  Neuroimmunomodulation       Date:  2008-11-26       Impact factor: 2.492

3.  Race/ethnicity moderates the relationship between depressive symptom severity and C-reactive protein: 2005-2010 NHANES data.

Authors:  Stephanie M Case; Jesse C Stewart
Journal:  Brain Behav Immun       Date:  2014-05-22       Impact factor: 7.217

4.  Screening for major and minor depression in a multiethnic sample of Asian primary care patients: a comparison of the nine-item Patient Health Questionnaire (PHQ-9) and the 16-item Quick Inventory of Depressive Symptomatology - Self-Report (QIDS-SR16 ).

Authors:  Sharon Cohan Sung; Charity Cheng Hong Low; Daniel Shuen Sheng Fung; Yiong Huak Chan
Journal:  Asia Pac Psychiatry       Date:  2013-10-03       Impact factor: 2.538

5.  Measurement invariance of the patient health questionnaire-9 (PHQ-9) depression screener in U.S. adults across sex, race/ethnicity, and education level: NHANES 2005-2016.

Authors:  Jay S Patel; Youngha Oh; Kevin L Rand; Wei Wu; Melissa A Cyders; Kurt Kroenke; Jesse C Stewart
Journal:  Depress Anxiety       Date:  2019-07-29       Impact factor: 6.505

Review 6.  Screening and case finding for major depressive disorder using the Patient Health Questionnaire (PHQ-9): a meta-analysis.

Authors:  Andrew Stephen Moriarty; Simon Gilbody; Dean McMillan; Laura Manea
Journal:  Gen Hosp Psychiatry       Date:  2015-06-18       Impact factor: 3.238

Review 7.  Central and Peripheral Inflammation Link Metabolic Syndrome and Major Depressive Disorder.

Authors:  Kenny L Chan; Flurin Cathomas; Scott J Russo
Journal:  Physiology (Bethesda)       Date:  2019-03-01

8.  The association between C-reactive protein levels and depression: Results from the northern Finland 1966 birth cohort study.

Authors:  Timo Liukkonen; Sylvi Silvennoinen-Kassinen; Jari Jokelainen; Pirkko Räsänen; Maija Leinonen; V Benno Meyer-Rochow; Markku Timonen
Journal:  Biol Psychiatry       Date:  2006-04-17       Impact factor: 13.382

Review 9.  CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies.

Authors:  Vyara Valkanova; Klaus P Ebmeier; Charlotte L Allan
Journal:  J Affect Disord       Date:  2013-07-17       Impact factor: 4.839

10.  Evaluation of Patients with Leukocytosis.

Authors:  Lyrad K Riley; Jedda Rupert
Journal:  Am Fam Physician       Date:  2015-12-01       Impact factor: 3.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.